Results 101 to 110 of about 1,887 (161)

Facial Erysipelas Following Pressurized Nasal Irrigation in Chronic Sinusitis: A Case Report. [PDF]

Cureus
Abrahim M, Abdelaziz N.
europepmc   +1 more source

A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: the ASSURE study.

Background Staphylococcus aureus bacteremia is a common infection associated with significant morbidity and mortality. Telavancin is a bactericidal lipoglycopeptide active against Gram-positive pathogens, including methicillin-resistant S. aureus (MRSA).
Barriere, Steven L., Miró Meda, José M., O'Riordan, William, Pullman, John, Stryjewski, Martin E., Fowler, Vance G., Lentnek, Arnold, Corey, G.Ralph, Tambyah, Paul Anantharajah, Kitt, Michael M.   +9 more
core  

Clinical Telavancin Failure in Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia. [PDF]

Cureus
Dao KT, D'Assumpcao C, Sharma R, Singh C, Kuran R, Heidari A.   +5 more
europepmc   +1 more source

Stealth MRSA: a diagnostic pitfall in invasive <i>Staphylococcus aureus</i> infection. [PDF]

ASM Case Rep
Karre TA, Kotula RJ, Goering RV.
europepmc   +1 more source

Epidemiology of Infections Caused by Gram-Positive Cocci-<i>Staphylococcus aureus</i>, <i>Streptococcus pneumoniae</i> and <i>Enterococcus faecium</i>: Antibiotic Resistance and Future Prospects. [PDF]

Microorganisms
Birlutiu V, Birlutiu RM.
europepmc   +1 more source

Comparative In Vitro Activity of New Lipoglycopeptides and Vancomycin Against Ocular Staphylococci and Their Toxicity on the Human Corneal Epithelium. [PDF]

Cornea, 2023
André C, Islam MM, Paschalis E, Bispo PJM.   +3 more
europepmc   +1 more source

FDA-Approved Antibacterials and Echinocandins. [PDF]

Antibiotics (Basel)
Al Musaimi O.
europepmc   +1 more source

Rapid in vitro activity of telavancin against Bacillus anthracis and in vivo protection against inhalation anthrax infection in the rabbit model. [PDF]

Antimicrob Agents Chemother
Lawrence WS, Peel JE, Slayden RA, Peterson JW, Baze WB, Hensel ME, Whorton EB, Beasley DWC, Cummings JE, Macias-Perez I.   +9 more
europepmc   +1 more source

Global burden of antimicrobial-resistant Staphylococcus aureus lower respiratory tract infections in older adults: a secondary analysis of the MICROBE database (1990-2021). [PDF]

BMC Infect Dis
Wei K, Liu Q.
europepmc   +1 more source

Clinical outcomes of dalbavancin versus standard therapy for non-severe skin and soft-tissue infections as well as bone and joint infections: a retrospective observational study. [PDF]

JAC Antimicrob Resist
Kitano T, Tsuzuki S, Yoshida S.
europepmc   +1 more source